Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Scientific Intake Ltd.

Latest From Scientific Intake Ltd.

US Approvals Analysis: Strong Q3 For Metabolic-Disease Devices

Of the five original PMAs approved last month by US FDA, two target diabetes and one targets obesity. In addition, the agency granted a de novo classification to another obesity device. Overall, FDA had a productive third-quarter for approvals and clearances.

Research & Development Approvals

The Fight Against Fat: Start-Ups Look To Serve A Vast Market With Minimally Invasive Bariatric Devices

Start-ups with an array of compelling devices are seeking to provide alternatives to invasive gastric bypass surgery and laparoscopic gastric banding for the millions of morbidly and moderately obese patients – but which ones will make it through the evolving FDA clinical process? In this issue we profile three young companies that hope to succeed: Aspire Bariatrics, EndoSphere, and Vibrynt.

Medical Device

Devices Treat Obesity Patients without Options

Early intervention is the general rule for success in treating many diseases, but in obesity, patients have to be in bad shape before they're eligible for the most efficacious treatments, which are surgical interventions. Companies with minimally invasive--and anatomy sparing--devices hope to change that paradigm.

The Skinny on Obesity Products

The total obesity products market, including drugs and device, is projected to reach more than $1.6 billion by 2010, growing at a compound annual rate of 36.1%. Success in this arena will depend on whether emerging drugs and devices can live up their hype and deliver the results needed to achieve regulatory approval and marketplace acceptance.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Gastrointestinal
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Scientific Intake Ltd.
  • Senior Management
  • William Longley, CEO
    Kevin Phillips, EVP, COO
    Don Hall, VP, R&D
    Robert S Hanggi, VP, Sales & Mktg.
  • Contact Info
  • Scientific Intake Ltd.
    Phone: (404) 264-2323
    3575 Piedmont Rd. NE, Bldg. 15
    Ste. 1050
    Atlanta, GA 30305